Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...

In November 2025, the UK government introduced the national "Government Strategy and Roadmap" for phasing out animal testing.[1] The US Food and Drug Administration (FDA) has also issued a roadmap and ...

A key part of consultants’ work is the global harmonization of CMC guidelines. Differences in regulatory requirements across regions can lead to inefficiencies in the drug development process.

Crafting effective, winning strategies requires a structured, methodical approach that uses the strengths of specialized tools. By combining the capabilities of Perplexity and NotebookLM, you can ...